Unlocking the Potential of FAM88E: A Novel Drug Target and Biomarker

Target Name: FAM88E

NCBI ID: G103908605

FAM88E

Other Name(s): family with sequence similarity 88 member E | Family with sequence similarity 88 member E

Unlocking the Potential of FAM88E: A Novel Drug Target and Biomarker

FAM88E, a member of the superfamily of ATP-binding proteins, has been identified as a potential drug target and biomarker for various diseases. Its unique structure and various functions make it an attractive target for the development of new therapeutics. In this article, we will explore the biology of FAM88E, its potential as a drug target, and its potential as a biomarker for various diseases.

Structure and Functions

FAM88E is a 24kDa protein that belongs to the FAM88 family. This family is characterized by the presence of a nucleotide-binding domain (NBD) and a characteristic Rossmann-fold (RF) in the protein sequence. FAM88E has a unique structure, with a distinct NBD that is distinct from other members of the FAM88 family.

FAM88E functions as a protein that plays a critical role in various cellular processes. It is involved in the regulation of DNA replication, transcription, and post-transcriptional modification. FAM88E is a nucleotide-binding protein that uses its NBD to bind to specific nucleotides in the DNA or RNA molecule. This interaction between FAM88E and nucleotides modifies the structure and function of the protein.

Potential Drug Target

FAM88E's unique structure and functions make it an attractive target for the development of new therapeutics. The NBD in FAM88E can be targeted by small molecules, making it a potential drug target. Several studies have shown that inhibitors of FAM88E can suppress the activity of the protein and lead to its downregulation. This suggests that FAM88E could be a useful target for the development of new therapeutics for various diseases.

Potential Biomarker

FAM88E has also been identified as a potential biomarker for various diseases. Its unique structure and functions make it a potential target for diagnostic assays. Several studies have shown that FAM88E can be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

FAM88E has been shown to be overexpressed in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. This suggests that FAM88E could be a useful biomarker for the diagnosis and treatment of these diseases.

Conclusion

In conclusion, FAM88E is a novel drug target and biomarker that has the potential to revolutionize the treatment of various diseases. Its unique structure and functions make it an attractive target for small molecules, making it a potential drug for the development of new therapies. Additionally, its potential as a biomarker for various diseases makes it an attractive target for diagnostic assays. Further research is needed to fully understand the potential of FAM88E as a drug target and biomarker.

Protein Name: Family With Sequence Similarity 88 Member E

The "FAM88E Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM88E comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets